IL6 and lung carcinoma: The data indicate that IL-6 not only promotes its own expression but also activates the STING pathway (as evidenced by increased STING expression) and enhances autophagic flux (reflected by higher P62 and LC3-2B levels) in these lung cancer cell lines.